ArticleWorld journal of gastroenterology2017
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.
Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The prevalence of clarithromycin-resistantPeerJ · 2023Pooled it
- Biochar filtration of drug-resistant bacteria and active pharmaceutical ingredients to combat antimicrobial resistance.Scientific reports · 2025Article
- Addressing the global challenge ofGut microbes reports · 2025Article
- Bioactive Properties ofPlants (Basel, Switzerland) · 2024Article
- Exploring the Molecular Mechanisms of Macrolide Resistance in Laboratory MutantAntibiotics (Basel, Switzerland) · 2024Article
- Antimicrobial combinations againstMicrobiology spectrum · 2024Article
- Article
- Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice.Journal of clinical laboratory analysis · 2023Review
- Multidrug resistance inFrontiers in microbiology · 2023Review
- The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication ofFrontiers in pharmacology · 2023Article
- Chemical Composition and In Vitro Anti-Plants (Basel, Switzerland) · 2022Article
- Extraction of antibacterial peptides againstArchives of medical science : AMS · 2022Article
- Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study.Current microbiology · 2021Article
- Article
- Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.BMC microbiology · 2019Article
- Development ofWorld journal of gastroenterology · 2019Review
- Increase in antibiotic resistantInfection and drug resistance · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the increasing prevalence of clarithromycin resistance, future of management of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.